Unknown

Dataset Information

0

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.


ABSTRACT: PURPOSE:Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive infantile brain tumors with poor survival. Recent advancements have highlighted significant molecular heterogeneity in AT/RT with an aggressive subgroup featuring overexpression of the MYC proto-oncogene. We perform the first comprehensive metabolic profiling of patient-derived AT/RT cell lines to identify therapeutic susceptibilities in high MYC-expressing AT/RT. EXPERIMENTAL DESIGN:Metabolites were extracted from AT/RT cell lines and separated in ultra-high performance liquid chromatography mass spectrometry. Glutamine metabolic inhibition with 6-diazo-5-oxo-L-norleucine (DON) was tested with growth and cell death assays and survival studies in orthotopic mouse models of AT/RT. Metabolic flux analysis was completed to identify combination therapies to act synergistically to improve survival in high MYC AT/RT. RESULTS:Unbiased metabolic profiling of AT/RT cell models identified a unique dependence of high MYC AT/RT on glutamine for survival. The glutamine analogue, DON, selectively targeted high MYC cell lines, slowing cell growth, inducing apoptosis, and extending survival in orthotopic mouse models of AT/RT. Metabolic flux experiments with isotopically labeled glutamine revealed DON inhibition of glutathione (GSH) synthesis. DON combined with carboplatin further slowed cell growth, induced apoptosis, and extended survival in orthotopic mouse models of high MYC AT/RT. CONCLUSIONS:Unbiased metabolic profiling of AT/RT identified susceptibility of high MYC AT/RT to glutamine metabolic inhibition with DON therapy. DON inhibited glutamine-dependent synthesis of GSH and synergized with carboplatin to extend survival in high MYC AT/RT. These findings can rapidly translate into new clinical trials to improve survival in high MYC AT/RT.

SUBMITTER: Wang SZ 

PROVIDER: S-EPMC6781869 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.

Wang Sabrina Z SZ   Poore Brad B   Alt Jesse J   Price Antoinette A   Allen Sariah J SJ   Hanaford Allison R AR   Kaur Harpreet H   Orr Brent A BA   Slusher Barbara S BS   Eberhart Charles G CG   Raabe Eric H EH   Rubens Jeffrey A JA  

Clinical cancer research : an official journal of the American Association for Cancer Research 20190712 19


<h4>Purpose</h4>Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive infantile brain tumors with poor survival. Recent advancements have highlighted significant molecular heterogeneity in AT/RT with an aggressive subgroup featuring overexpression of the <i>MYC</i> proto-oncogene. We perform the first comprehensive metabolic profiling of patient-derived AT/RT cell lines to identify therapeutic susceptibilities in high MYC-expressing AT/RT.<h4>Experimental design</h4>Metabolites were extracted  ...[more]

Similar Datasets

| S-EPMC4046281 | biostudies-literature
| S-EPMC4483069 | biostudies-literature
| S-EPMC6656328 | biostudies-literature
| S-EPMC9218972 | biostudies-literature
| S-EPMC7821707 | biostudies-literature
| S-EPMC5814281 | biostudies-literature
| S-EPMC4617150 | biostudies-literature
| S-EPMC5570172 | biostudies-literature
| S-EPMC6279935 | biostudies-literature
| S-EPMC7339881 | biostudies-literature